Selected books published by thinkBiotech
The leading textbook and primer on the business of biotechnology
From Science to Solutions
Advanced Strategies For Innovative Growth Companies
Showcase your expertise
thinkBiotech publishes the Journal of Commercial Biotechnology, the authorotative source for leading thinking on biotechnology business management. The Journal of Commercial Biotechnology welcomes research papers, case studies, strategic guidance, and industry perspectives. The JCB also welcomes shorter commentaries on industry developments. More details and sample papers are available at http://www.CommercialBiotechnology.com.
BiotechBlog guest posts are available for informative, non-commercial messages. This non-refereed outlet is more inclusive than the Journal of Commercial Biotechnology and is an excellent outlet for your industry perspectives and practical guidance. Submission guidelines are at http://www.biotechblog.com/spread-your-message-with-biotechblog, and existing guest content is at http://www.biotechblog.com/category/guest-content/.
Please send a short pitch using the contact form. Please include a author headshot/company logo and author/company bio for the byline along with any submissions.
thinkBiotech publishes books under the Logos Press imprint. Logos Press specializes in reference and text books addressing the use of knowledge to make intelligent strategic decisions. Recent titles are posted at http://logos-press.com/books/. If you are interested in writing a book or editing a compilation , please check out the submission guidelines at http://logos-press.com/submission.php for guidance.
Named one of the 100 most influential people in biotechnology by Scientific American.
Yali Friedman, Ph.D., is a publisher and entrepreneur. He is head of data analytics for Scientific American Custom Media and publisher of the Journal of Commercial Biotechnology. His first book, Building Biotechnology, is used as a course text in dozens of biotechnology programs. He also publishes data analytics products at DrugPatentWatch.com and PatentStat.com.
Dr. Friedman has strong exposure to leading issues in international biotechnology. In 2008 he developed, and continues to produce, the Scientific American Worldview scorecard. The Worldview scorecard is the leading measure of global biotechnology innovation, profiling biotechnology industries and innovation capacity in more than 50 countries. It has been presented at the annual Biotechnology Industry Organization international conference, at biotechnology industry development forums for US federal agencies, and in forums from Asia to South America.
Before joining Scientific American, Dr. Friedman worked in technology-based economic development, where he conducted extensive primary research, including surveys, forums, and hundreds of interviews, to develop regional plans to spur economic growth in US states and metropolitan areas.
1133 15th Street Northwest, 12th floor
Washington DC 20005